Evidence map›Paper›PMID 29312120›Full record

ArticleFrontiers in neurology2017

Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate.

Jan Kudlacek, Jan Chvojka, Antonin Posusta, Lubica Kovacova, Seung Bong Hong, Shennan Weiss, Kamila Volna, Petr Marusic, Jakub Otahal, Premysl Jiruska

Abstract read
In one paragraph

Article in Frontiers in neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jan KudlacekDepartment of Developmental Epileptology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czechia.
Jan ChvojkaDepartment of Developmental Epileptology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czechia.
Antonin PosustaDepartment of Developmental Epileptology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czechia.
Lubica KovacovaDepartment of Developmental Epileptology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czechia.
Seung Bong HongDepartment of Neurology, Samsung Medical Center, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University School of Medicine, Seoul, South Korea.
Shennan WeissDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA, United States.
Kamila VolnaDepartment of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.
Petr MarusicDepartment of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.
Jakub OtahalDepartment of Developmental Epileptology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czechia.
Premysl JiruskaDepartment of Developmental Epileptology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological high-frequency oscillations are a novel marker used to improve the delineation of epileptogenic tissue and, hence, the outcome of epilepsy surgery. Their practical clinical utilization is curtailed by the inability to discriminate them from physiological oscillations due to frequency overlap. Although it is well documented that pathological HFOs are suppressed by antiepileptic drugs (AEDs), the effect of AEDs on normal HFOs is not well known. In this experimental study, we have explored whether physiological HFOs (sharp-wave ripples) of hippocampal origin respond to AED treatment. The results show that application of a single dose of levetiracetam or lacosamide does not reduce the rate of sharp-wave ripples. In addition, it seems that these new generation drugs do not negatively affect the cellular and network mechanisms involved in sharp-wave ripple generation, which may provide a plausible explanation for the absence of significant negative effects on cognitive functions of these drugs, particularly on memory.

Indexed as

antiepileptic drugshigh-frequency oscillationshippocampusin vivolacosamidelevetiracetamripplessharp-wave ripples

Identifiers

PMID29312120
PMCPMC5742623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.